Measurement of Ceramide and Sphingolipid Metabolism in Tumors: Potential Modulation of Chemotherapy
Ceramide is a bioactive lipid involved in the induction of apoptosis and is the precursor to several sphingolipids, including sphingomyelin, the gangliosides, and sphingosine. Ceramide production is increased in response to stress and toxic agents. Because modulation of ceramide levels has been shown to affect sensitivity and/or resistance to therapeutic agents, it will be important to assess the activity of sphingolipid metabolic pathways when investigating the mode of action of antitumor drugs. This chapter summarizes protocols for quantitating the level of apoptosis, the activities of acidic sphingomyelinase, neutral sphingomyelinase, glycosylceramide synthase, sphingomyelin synthase, and ceramidase, and the amount of ceramide in tumor xenografts in nude mice.
- Transformation of the Human Ovarian Surface Epithelium with Genetically Defined Elements
- Oncolytic Viral Therapy Using Reovirus
- Promoter Methylation in Head and Neck Tumorigenesis
- Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development
- Electrophoretic Mobility Shift Analysis of the DNA Binding of Tumor Suppressor Gene Products
- Purification of Annexin V and Its Use in the Detection of Apoptotic Cells
- COLD-PCR Enriches Low-Level Variant DNA Sequences and Increases the Sensitivity of Genetic Testing
- Molecular Characterization of Human Papillomaviruses by PCR and In Situ Hybridization
- 細胞穩(wěn)定轉(zhuǎn)染建系后再轉(zhuǎn)染的問題
- 真核細胞表達系統(tǒng)